FindTrial
Sign In

Pain relieving capacity of combined femoral and sciatic nerve block with help of ultrasound using dexamethasone(steroid) as an additive to levobupivacaine(local anesthetic) versus levobupivacaine alone in foot and ankle surgeries: A randomized controlled clinical study

Analgesic efficacy of ultrasound-guided combined femoral and sciatic nerve block using dexamethasone as an adjuvant to levobupivacaine versus levobupivacaine alone in foot and ankle surgeries: A randomized double-blind controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050243
Enrollment
30
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: Intervention agent- Levobupivacaine and dexamethasone Comparator agent- Levobupivacaine alone: Ultrasound guided femoral and popliteal sciatic nerve block using only levobupivacaine as
SonoSite, Inc. Bothell, WA, USA), via an in-plane approach after visualization of the nerve sheaths. Duration - 20 to 30 minutes Control Intervention1: Levobupivacaine (23 ml of 0.5%) and Normal salin
SonoSite, Inc. Bothell, WA, USA), via an in-plane approach after visualization of the nerve sheaths. Duration - 20 to 30 minutes

Sponsors

All India Institute of Medical Sciences, Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of trauma scheduled for unilateral foot and ankle surgery 2. Patients with ASA (American Society of Anesthesiologists) grade I-II

Exclusion criteria

Exclusion criteria: 1. Uncontrolled Diabetes Mellitus 2. Allergy to local anesthetics 3. Coagulopathy 4. Pregnancy 5. Skin infection at the injection site 6. Patients not willing to give consent 7. Haemodynamically unstable patients

Design outcomes

Primary

MeasureTime frame
To estimate the duration of analgesia (time to first rescue analgesia)in both the groupsTimepoint: Within 24 hours—

Secondary

MeasureTime frame
1.To determine the onset time and duration of sensory and motor blockTimepoint: 1. Within 24 hours—

Countries

India

Contacts

Public ContactDr Ajitesh Sahu

All India Institute of Medical sciences, Bhubaneswar

sahu.ajitesh84@gmail.com8826727889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026